ICE vs PBYI · P/E 37, rev $7.28B vs P/E 4.3, rev $56.5M
Intercontinental Exchange Inc (ICE) versus Puma Biotechnology Inc (PBYI) — a side-by-side from cached financials, not a winner call.
Intercontinental Exchange Inc (ICE) is a financial data & stock exchanges company listed on US.
Puma Biotechnology Inc (PBYI) is a biotechnology company listed on US.
Latest reported ICE revenue for 2026-06-30 was $7.28B. Net income was $2.37B. Revenue was up 98.5% from 2026-03-31 to 2026-06-30. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
Latest reported PBYI revenue for 2026-06-30 was $56.5M. Net income was $8.2M. Revenue was up 26.1% from 2026-03-31 to 2026-06-30. PBYI currently screens at market cap $165.3M and trailing P/E 4.3.
ICE currently screens at market cap $103.55B and trailing P/E 37.3. PBYI currently screens at market cap $165.3M and trailing P/E 4.3.
Not investment advice. Open the ICE and PBYI stock pages for the full models.
Not investment advice.